We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
Results 1 to 5 of 17
Most popular |Most recent


The USMCA: What does it mean for patents and the pharmaceutical industry?

USA, Canada - October 5 2018 In a joint statement on September 30, 2018, the United States and Canadian Governments announced that they reached an agreement, alongside Mexico, on...

Justin Smith, Jenny Thistle, Jennifer L. Wilkie.


From TPP to CPTPP: Suspensions to IP Provisions

Canada - February 7 2018 On January 23, 2018, Canada and 10 other signatories of the now-defunct Trans-Pacific Partnership (TPP) concluded a series of negotiations in Tokyo...

Kristen Kilroy, Justin Smith.


The TPP new rights for pharmaceutical patent holders in Canada

Canada - November 13 2015 The Canadian Government released the official consolidated text of the Trans-Pacific Partnership (TPP) agreement on Nov., 5, 2015. This follows the...

Kelly A. McClellan, PhD, Justin Smith.


The Trans-Pacific partnership: changes for patents and pharmaceuticals?

Asia-Pacific, Canada - October 8 2015 Changes may be on the horizon for Canada’s legal and regulatory regime for patents and pharmaceuticals. Included in the Trans-Pacific Partnership...

Kelly A. McClellan, PhD.


CETA what does it mean for IP in Canada?

Canada, European Union - October 2 2014 Almost a year following an agreement-in-principle between Canada and the European Union, the official full text of the Canada-European Union...

Laura Morrison, Monique M. Couture.